C. Silva

发表

In Silico Search and Toxicology Prediction of Novel Potential β-Secretase Inhibitors in Alzheimers Disease

V. B. Silva, A. M. Namba, Daniela Godoy Pantalena, 2009 .

Computational Investigation of Antifungal Compounds Using Molecular Modeling and Prediction of ADME/Tox Properties

H. A. Favacho, L. Hage-Melim, Cleydson B. R. Santos, 2015 .

Rational Design of Antimalarial Drugs Using Molecular Modeling and Statistical Analysis.

H. A. Favacho, Cleydson B. R. Santos, C. Silva, 2015, Current pharmaceutical design.

Virtual Screening and Toxicology Prediction of Novel Potential Non- Nucleoside Reverse Transcriptase Inhibitors

V. B. Silva, A. M. Namba, C. Silva, 2009 .

Discovery of Novel Leishmanicidal Drugs with Potential L-type Calcium Channel Blockage, Designed by Similarity-Based Virtual Screening Approaches

C. Silva, L. Freitas-Junior, L. Alcântara, 2018 .

Chemoinformatics: Directions Toward Combating Neglected Diseases

C. Taft, T. França, H. Castro, 2018 .

Cyclooligomerisation of azido-alkyne-functionalised sugars: synthesis of 1,6-linked cyclic pseudo-galactooligosaccharides and assessment of their sialylation by Trypanosoma cruzi trans-sialidase

I. Carvalho, R. Field, S. Nepogodiev, 2010 .

The fungal metabolite eugenitin as additive for Aspergillus niveus glucoamylase activation

J. A. Jorge, M. Polizeli, V. B. Silva, 2012 .

Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design

C. Taft, C. Silva, E. Semighini, 2011 .

Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy.

D. Kawano, I. Carvalho, V. B. Silva, 2011, Memorias do Instituto Oswaldo Cruz.